Effect of Danhong injection on prognosis and inflammatory factor expression in patients with acute coronary syndrome during the perioperative period of percutaneous coronary intervention: A systematic review and meta-analysis
ObjectivesIn China, Danhong injection (DHI) is recommended by expert consensus and is widely used in the perioperative management of patients with acute coronary syndrome (ACS). This study investigates the effect of perioperative DHI administration and the timing of DHI administration on patients wi...
Main Authors: | Yuxuan Li, Dong Li, Wujiao Wang, Xingxing Li, Peng Li, Yuanyuan Zhang, Qian Lin, Yan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1029387/full |
Similar Items
-
Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
by: Qian Niu, et al.
Published: (2022-01-01) -
The Therapeutic Efficacy of Danhong Injection Combined With Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
by: Jun-Bo Zou, et al.
Published: (2018-06-01) -
Initiate Danhong Injection before or after percutaneous coronary intervention for microvascular obstruction in ST-elevation myocardial infarction (DIRECTION): study protocol for a randomized controlled trial
by: Xiaoyu Zhang, et al.
Published: (2020-01-01) -
Danhong Injection Price Trend and Its Utilization by Coronary Heart Disease Patients: Evidence From Hospital Records in China
by: Liming Liu, et al.
Published: (2022-05-01) -
Cost-effectiveness of radial vs. femoral approach in primary percutaneous coronary intervention in STEMI – Randomized, control trial
by: Łukasz Kołtowski, et al.
Published: (2016-05-01)